BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17622952)

  • 1. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
    Coimbra RS; Loquet G; Leib SL
    Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
    Kim HH; Addison J; Suh E; Trune DR; Richter CP
    Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
    Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
    J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
    Klein M; Koedel U; Pfister HW; Kastenbauer S
    Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
    Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
    Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of dexamethasone on hearing ability in children with pneumococcal meningitis.
    Ozen M; Kanra G; Kara A; Ataş A; Seçmeer G; Ceyhan M; Cengiz AB; Belgin E
    Turk J Pediatr; 2008; 50(1):23-9. PubMed ID: 18365587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.
    Perny M; Roccio M; Grandgirard D; Solyga M; Senn P; Leib SL
    J Neurosci; 2016 Jul; 36(29):7740-9. PubMed ID: 27445150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
    Muri L; Grandgirard D; Buri M; Perny M; Leib SL
    J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
    Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
    J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.
    Wald ER; Kaplan SL; Mason EO; Sabo D; Ross L; Arditi M; Wiedermann BL; Barson W; Kim KS; Yogov R
    Pediatrics; 1995 Jan; 95(1):21-8. PubMed ID: 7770303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy.
    Addison J; Kim HH; Richter CP
    Laryngoscope; 2006 Feb; 116(2):279-82. PubMed ID: 16467719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
    Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
    Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of hearing loss in an animal model of pneumococcal meningitis.
    Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
    Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol.
    Peltola H; Roine I; Fernández J; González Mata A; Zavala I; Gonzalez Ayala S; Arbo A; Bologna R; Goyo J; López E; Miño G; Dourado de Andrade S; Sarna S; Jauhiainen T
    Pediatrics; 2010 Jan; 125(1):e1-8. PubMed ID: 20008417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis.
    Bhatt SM; Cabellos C; Nadol JB; Halpin C; Lauretano A; Xu WZ; Tuomanen E
    Pediatr Infect Dis J; 1995 Feb; 14(2):93-6. PubMed ID: 7746714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Hippocampal Regeneration by Adjuvant Dexamethasone in Experimental Infant Rat Pneumococcal Meningitis.
    Bally L; Grandgirard D; Leib SL
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1841-6. PubMed ID: 26824948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
    Liu X; Han Q; Sun R; Li Z
    Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.